Tirzepatide is a synthetic 39-amino-acid peptide engineered to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual-agonist design provides a defined research tool for examining how two incretin-receptor pathways interact within the same experimental system.
Common research applications include receptor-binding and activation assays, downstream signal-transduction studies, structure-activity comparisons, and controlled in vitro or preclinical models of glucose and lipid metabolism. The molecular formula and weight shown in the product characteristics refer to the free-base structure.
Supplied as lyophilized research material. Identity and measured purity are batch-specific and should be confirmed using the corresponding certificate of analysis.
Research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, cosmetic, food, drug, or consumption purposes.
| CAS Number | 2023788-19-2 |
|---|---|
| Molecular Weight | 4813.45 g/mol |
| Formula | C225H348N48O68 |
| Peptide Length | 39 amino acids |
| Physical State | Lyophilized powder |
| Purity | > 99% HPLC |
Be the first to share your experience with this product.
Share your experience
Reviews are checked before they are published. Your email is used only for review administration and is never displayed.
Quality Documentation
Review the current product Certificate of Analysis in your browser or download the PDF for your records.
